More specifically, in patients with NAFLD, the increased visceral adipocyte mass and the disinhibited activity of hormone-sensitive lipase in insulin, increase triglyceride hydrolysis, leading to a subsequent increase of free fatty acids (FFA) especially in portal venous blood and consequently increased FFA liver uptake. Here, LIPE is linked to metabolic dysfunction-associated steatotic liver disease.